Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Multiple Copies of MLL Is The Most Commonly Detected Cytogenetic Abnormality In Newly Diagnosed Multiple Myeloma and May Modify Disease Risk

Chrystal Landry, MD, Dory Londono, Sean M. Devlin, PhD, Alex Lesokhin, MD, Nikoletta Lendvai, MD PhD, Hani Hassoun, MD, David J Chung, MD PhD, Guenther Koehne, MD, PhD, Suresh C. Jhanwar, PhD, Sergio A Giralt, MD, Heather Landau, MD

Blood (2013) 122 (21): 1910.

https://doi.org/10.1182/blood.V122.21.1910.1910

Published: 2013

Journal Articles

T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation For Patients With Relapsed Multiple Myeloma and High-Risk Cytogenetics Permits Long-Lasting Remissions In The Absence Of Graft-Versus-Host Disease

Guenther Koehne, MD, PhD, Sean M. Devlin, PhD, Heather Landau, MD, Hani Hassoun, MD, Alex Lesokhin, MD, Nikoletta Lendvai, MD PhD, David J Chung, MD PhD, Christina Bravo, MS, Sergio Giralt, MD

Blood (2013) 122 (21): 2115.

https://doi.org/10.1182/blood.V122.21.2115.2115

Published: 2013

Journal Articles

Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Kevin Wood, MD, Sergio A Giralt, MD, Guenther Koehne, MD, PhD, David Chung, MD PhD, Nikoletta Lendvai, MD PhD, Hani Hassoun, MD, Alex Lesokhin, MD, Elizabeth Hoover, Sean Devlin, PhD, Heather Landau, MD

Blood (2012) 120 (21): 4550.

https://doi.org/10.1182/blood.V120.21.4550.4550

Published: 2012

Journal Articles

Reactive Polyclonal Gammopathy Associated with Polyclonal Plasmacytosis Is Common in Patients with Multiple Myeloma Receiving Prolonged Lenalidomide Therapy: A Retrospective Study of 104 Patients

Dmitriy Zamarin, MD PhD, Sean Devlin, PhD, Maria Arcila, MD, Sergio A. Giralt, MD, Heather Landau, MD, Alex Lesokhin, MD, Nikoletta Lendvai, MD PhD, David Chung, MD PhD, Danielle Chimento, BA, Dilip Babu, MD, Hani Hassoun, MD

Blood (2012) 120 (21): 4033.

https://doi.org/10.1182/blood.V120.21.4033.4033

Published: 2012

Journal Articles

Polyclonal IgA Gammopathy Associated with Polyclonal Plasmacytosis in Patients Receiving Lenalidomide Maintenance Therapy

Dmitriy Zamarin, MD PhD, Maria Arcila, MD, Sergio A Giralt, MD, Nikoletta Lendvai, MD PhD, Heather Landau, MD, Alex Lesokhin, MD, David Chung, MD PhD, Danielle Chimento, BA, Hani Hassoun, MD

Blood (2011) 118 (21): 5130.

https://doi.org/10.1182/blood.V118.21.5130.5130

Published: 2011

Journal Articles

T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics

Guenther Koehne, MD PhD, Heather Landau, MD, Hani Hassoun, MD, Alex Lesokhin, MD, Nikoletta Lendvai, MD PhD, Michael A. Rosenzweig, MD, Glenn Heller, PhD, Sergio Giralt, MD

Blood (2011) 118 (21): 1992.

https://doi.org/10.1182/blood.V118.21.1992.1992

Published: 2011

Journal Articles

Patterns of Disease Relapse and Progression in Patients with Multiple Myeloma After First Line Therapy with Autologous Stem Cell Transplantation: Implications for Patient Monitoring After Transplantation

Dmitriy Zamarin, MD PhD, Manisha Bhutani, MD, Danielle Chimento, BA, Sergio Giralt, MD, Nikoletta Lendvai, MD PhD, Heather Landau, MD, Alex Lesokhin, MD, David Chung, MD PhD, Dilip Babu, MD, Hani Hassoun, MD

Blood (2011) 118 (21): 825.

https://doi.org/10.1182/blood.V118.21.825.825

Published: 2011

Journal Articles

Maintained Hematologic and Organ Responses at Two Years Following Stem Cell Transplant In Systemic Light-Chain Amyloidosis (AL) Using Short-Course Bortezomib and Dexamethasone Consolidation Therapy

Heather Landau, MD, Hani Hassoun, MD, Michael A. Rosenzweig, MD, Christina Bello, Elizabeth Hoover, Elyn Riedel, Alex Lesokhin, MD, Nikoletta Lendvai, MD, PhD, Adam Cohen, MD, Stephen Nimer, Raymond L. Comenzo, MD

Blood (2010) 116 (21): 2391.

https://doi.org/10.1182/blood.V116.21.2391.2391

Published: 2010

NARROW

Multiple Copies of MLL Is The Most Commonly Detected Cytogenetic Abnormality In Newly Diagnosed Multiple Myeloma and May Modify Disease Risk

T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation For Patients With Relapsed Multiple Myeloma and High-Risk Cytogenetics Permits Long-Lasting Remissions In The Absence Of Graft-Versus-Host Disease

Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Reactive Polyclonal Gammopathy Associated with Polyclonal Plasmacytosis Is Common in Patients with Multiple Myeloma Receiving Prolonged Lenalidomide Therapy: A Retrospective Study of 104 Patients

Polyclonal IgA Gammopathy Associated with Polyclonal Plasmacytosis in Patients Receiving Lenalidomide Maintenance Therapy

T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics

Patterns of Disease Relapse and Progression in Patients with Multiple Myeloma After First Line Therapy with Autologous Stem Cell Transplantation: Implications for Patient Monitoring After Transplantation

Maintained Hematologic and Organ Responses at Two Years Following Stem Cell Transplant In Systemic Light-Chain Amyloidosis (AL) Using Short-Course Bortezomib and Dexamethasone Consolidation Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only